-
Rainmed Medical’s caIMR System Receives NMPA Approval for Coronary Artery Function Measurement
•
China-based Rainmed Medical Limited has announced that it has received market approval from the National Medical Products Administration (NMPA) for its innovative coronary artery function measurement system, the caIMR system. Microcirculatory Resistance Index (IMR) and Its Clinical SignificanceThe microcirculatory resistance index (IMR) is a quantitative method used to evaluate the…
